IFNA1 and chronic hepatitis B virus infection: Dogan et al. [12] compared the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients and found that there were no significant differences between Peg-IFNα-2a and Peg-IFNα-2b treatment groups in achieving an SVR and undetectable HBV-DNA levels.